(Q37755276)

22 August 2017

Monoclonal antibody-induced cytokine-release syndrome (English)

1 reference

22 August 2017

1 reference

1 reference

Peter J Bugelski

1

1 reference

22 August 2017

Ram Achuthanandam

2

1 reference

22 August 2017

Renold J Capocasale

3

1 reference

22 August 2017

George Treacy

4

1 reference

22 August 2017

Esther Bouman-Thio

5

1 reference

22 August 2017

1 September 2009

1 reference

Expert Review of Clinical Immunology

22 August 2017

1 reference

22 August 2017

5

1 reference

22 August 2017

5

1 reference

22 August 2017

499-521

1 reference

Adverse side-effects to biological agents

22 August 2017

1 reference

The pathogenesis of sepsis. Factors that modulate the response to gram-negative bacterial infection

21 January 2018

1 reference

Forecasting the cytokine storm following systemic interleukin (IL)-2 administration

21 January 2018

1 reference

Cytokine-release syndrome: overview and nursing implications

21 January 2018

1 reference

Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma

21 January 2018

1 reference

Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity

21 January 2018

1 reference

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells

21 January 2018

1 reference

Alemtuzumab: a novel monoclonal antibody

21 January 2018

1 reference

Subcutaneous administration of alemtuzumab in simultaneous pancreas-kidney transplantation.

21 January 2018

1 reference

Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial

21 January 2018

1 reference

Remission induction in Behçet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H.

21 January 2018

1 reference

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

21 January 2018

1 reference

Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.

21 January 2018

1 reference

Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.

21 January 2018

1 reference

Non-cardiogenic pulmonary edema during basiliximab induction in three adolescent renal transplant patients

21 January 2018

1 reference

Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.

21 January 2018

1 reference

21 January 2018

1 reference

The therapeutic use of rituximab in non-Hodgkin's lymphoma

21 January 2018

1 reference

In vitro characterization of five humanized OKT3 effector function variant antibodies.

21 January 2018

1 reference

Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions

21 January 2018

1 reference

Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum.

21 January 2018

1 reference

Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis

21 January 2018

1 reference

21 January 2018

1 reference

Monoclonal antibody clearance. Impact of modulating the interaction of IgG with the neonatal Fc receptor

21 January 2018

1 reference

Signaling signatures and functional properties of anti-human CD28 superagonistic antibodies

21 January 2018

1 reference

Potential anaphylactic shock with abciximab readministration

21 January 2018

1 reference

CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14).

21 January 2018

1 reference

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose

21 January 2018

1 reference

Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders

21 January 2018

1 reference

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.

21 January 2018

1 reference

Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics

21 January 2018

1 reference

N-Glycolylneuraminic acid in human tumours

21 January 2018

1 reference

A humanized anti-CD3 antibody, HuM291, with low mitogenic activity, mediates complete and reversible T-cell depletion in chimpanzees

21 January 2018

1 reference

Loss of Siglec expression on T lymphocytes during human evolution

21 January 2018

1 reference

A CD28 superagonistic antibody elicits 2 functionally distinct waves of T cell activation in rats

21 January 2018

1 reference

Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies.

21 January 2018

1 reference

Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees

21 January 2018

1 reference

Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/γcnull mice model

21 January 2018

1 reference

Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific

21 January 2018

1 reference

Comparison of intracellular cytokine production with extracellular cytokine levels using two flow cytometric techniques

21 January 2018

1 reference

CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells.

21 January 2018

1 reference

Cytokine production in peripheral blood cells during and outside the pollen season in birch-allergic patients and non-allergic controls.

21 January 2018

1 reference

H5N1 influenza: a protean pandemic threat

21 January 2018

1 reference

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

21 January 2018

1 reference

Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever

21 January 2018

1 reference

The paediatric cytarabine syndrome can be viewed as a drug-induced cytokine release syndrome.

21 January 2018

1 reference

Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia.

21 January 2018

1 reference

Anti-oxidants inhibit the enhancement of the immune response caused by oil adjuvants

21 January 2018

1 reference

On the prediction of the human response: a recycled mechanistic pharmacokinetic/pharmacodynamic approach.

21 January 2018

1 reference

Regulatory T cells in cancer

21 January 2018

1 reference

Pentoxifylline does not prevent the cytokine-induced first dose reaction following OKT3--a randomized, double-blind placebo-controlled study

21 January 2018

1 reference

Monoclonal antibodies as therapeutic agents for cancer

21 January 2018

1 reference

Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study

21 January 2018

1 reference

Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events

21 January 2018

1 reference

Severe infusion reaction induced by trastuzumab: A case report

21 January 2018

1 reference

FDA drug approval summary: panitumumab (Vectibix).

21 January 2018

1 reference

Successful management of infusion reaction accompanying the start of cetuximab therapy.

21 January 2018

1 reference

Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer

21 January 2018

1 reference

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in established monkey collagen-induced arthritis.

21 January 2018

1 reference

A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation

21 January 2018

1 reference

IC14, a CD14 specific monoclonal antibody, is a potential treatment for patients with severe sepsis

21 January 2018

1 reference

Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma

21 January 2018

1 reference

Novel monoclonal antibodies for the treatment of chronic lymphocytic leukemia

21 January 2018

1 reference

CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance

21 January 2018

1 reference

Complement-targeted therapeutics

21 January 2018

1 reference

Abciximab: a review and update for clinicians

21 January 2018

1 reference

Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection.

21 January 2018

1 reference

Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy

21 January 2018

1 reference

New therapeutic directions for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathways

21 January 2018

1 reference

Therapeutic anti-VEGF antibodies

21 January 2018

1 reference

Rabbit antithymocyte globulin induction therapy in adult renal transplantation

21 January 2018

1 reference

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

21 January 2018

1 reference

An interferon-gamma-related cytokine storm in SARS patients

21 January 2018

1 reference

Cytokine storm in acute pancreatitis

21 January 2018

1 reference

The cytokine storm in multiple sclerosis

21 January 2018

1 reference

Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatment

21 January 2018

1 reference

In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants

21 January 2018

1 reference

A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis

21 January 2018

1 reference

Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors

21 January 2018

1 reference

Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways.

21 January 2018

1 reference

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.

21 January 2018

1 reference

The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties

21 January 2018

1 reference

Inflammation in autoimmunity: receptors for IgG revisited

21 January 2018

1 reference

Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,)

21 January 2018

1 reference

Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies

21 January 2018

1 reference

T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

21 January 2018

1 reference

A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4.

21 January 2018

1 reference

Rituximab as monotherapy for elicited xenoreactive antibody responses.

21 January 2018

1 reference

Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.

21 January 2018

1 reference

Extrathymic CD4/CD8 double positive T cells

21 January 2018

1 reference

Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms

21 January 2018

1 reference

Mutations in squirrel monkey glucocorticoid receptor impair nuclear translocation

21 January 2018

1 reference

Differential effects of administration of a human anti-CD4 monoclonal antibody, HM6G, in nonhuman primates

21 January 2018

1 reference

Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines

21 January 2018

1 reference

Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies

21 January 2018

1 reference

Simultaneous detection of eight analytes in human serum by two commercially available platforms for multiplex cytokine analysis

21 January 2018

1 reference

Cytokine quantitation: technologies and applications

21 January 2018

1 reference

The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes

21 January 2018

1 reference

Re-evaluation of Benefits of BRCA1/2 Testing

21 January 2018

1 reference

The strange case of TGN1412

21 January 2018

1 reference

In Vivo Pharmacodynamic Effects of Hu1D10 (Remitogen), a Humanized Antibody Reactive Against a Polymorphic Determinant of HLA-DR Expressed on B Cells

21 January 2018

1 reference

Novel therapies targeting the immune system: CTLA4 blockade with tremelimumab (CP-675,206), a fully human monoclonal antibody

21 January 2018

1 reference

Enhancement of T cell activation by immobilized hu5C8 (anti-CD40L) monoclonal antibody

21 January 2018

1 reference

Transfer of a functional human immune system to mice with severe combined immunodeficiency

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.09.31

1 reference

22 August 2017

1 reference